DAIC

OCTOBER 30, 2024

30, 2024 — HeartLung Technologies , a developer of AI tools for early detection of heart disease, lung cancer and other conditions announced that its AI-enabled Automated Cardiac Chambers Volumetry (AutoChamber) recently received “Breakthrough Medical Device” designation and marketing authorization from the U.S. “By

Cancer 45

Cancer Atrial Fibrillation Sudden Cardiac Death Heart Failure 45

DAIC

JANUARY 23, 2024

Better reimbursement for hospitals leads to improved accessibility to this technology, which is a win for everyone involved, most notably patients.” HeartFlow remains dedicated to reshaping cardiovascular care and ensuring that hospitals have access to comprehensive, accurate, and efficient solutions in precision coronary care.

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

FEBRUARY 13, 2024

According to the company, Earls is a leader within the field of radiology and specializes in applications of advanced imaging technologies in cardiovascular care. He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. Earls, MD , Chief Medical Officer of Cleerly.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

DAIC

JULY 18, 2024

Cardiovascular disease is the most common cause of death and disability globally, largely driven by myocardial infarction and ischemic stroke caused by atherosclerosis (plaque build-up in the arteries).

Plaque 105

Plaque Heart Attack Heart attacks Cardiovascular Disease 105

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

Cardiometabolic Health Congress

JULY 25, 2024

This year’s renowned open-concept exhibit hall will feature industry-leading companies presenting their innovative products, technologies, and services designed to assist practitioners in delivering the best whole-patient care possible. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.

Education 100

Education Innovation Risk Factors Obesity 100

DAIC

JANUARY 19, 2024

milla1cf Fri, 01/19/2024 - 10:55 January 19, 2024 — Orchestra BioMed , a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized in the BACKBEAT pivotal study in late December 2023. billion adults worldwide.

Pacemaker 105

Pacemaker Hypertension Blood Pressure Kidney Disease 105

DAIC

APRIL 9, 2024

Technological innovations have made catheter ablation safer and more effective than ever before,” Tzeis, who added, “For example, we now have pulsed field ablation which uses high energy electrical pulses to treat atrial fibrillation without damaging the nerves or oesophagus. The risk of death is extremely low (0.05-0.1%). 2018;11(7):e006350.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Heart Rhythm Blood Clot 105

Dr. Paddy Barrett

AUGUST 1, 2023

Historically, the radiation required to perform CTCA scans was relatively high, but with the advent of newer scanning technologies, that dose has been significantly reduced 1. A CT CAC scan can only identify if there is calcified atherosclerosis, where it is and to what extent. And it matters. They are not fantastic odds, in my view.

Coronary Angiogram 52

Coronary Angiogram Plaque Coronary Artery Disease Chest Pain 52

All About Cardiovascular System and Disorders

MAY 19, 2024

Brachiocephalic artery access without sternotomy for TAVR has been described as a Cutting-Edge Technology in a paper which has been just accepted in the JACC Asia [1]. Contralateral or left atherosclerosis in the carotid artery with significant stenosis or occlusion was a contraindication for this approach.

Aortic valve 40

Aortic valve Aortic TAVR Open-Heart Surgery 40

Dr. Paddy Barrett

AUGUST 22, 2023

Share For those with defective LDL receptors, as seen in familial hyperlipidemia, APOB particles are not cleared effectively, and concentrations rise, causing atherosclerosis 4. Which increases the risk of atherosclerosis. Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res.

Cholesterol 52

Cholesterol Dementia Coronary Artery Disease Cardiovascular Disease 52

Wellnest

DECEMBER 21, 2022

Technological advancements have revolutionized the medical industry; now, portable ECG devices are also available. This condition is also called atherosclerosis. Lead wires connect these patches to the ECG machine. The machine prints out a graph containing information about the heart's activity.

Cardiac Arrest 52

Cardiac Arrest Heart Attack Heart attacks Atrial Fibrillation 52

Cardiometabolic Health Congress

AUGUST 8, 2024

Key contributions: Advanced cardiac imaging (e.g., high-sensitivity troponin, NT-proBNP) in risk stratification Utilization of advanced echocardiographic techniques (e.g.,

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Dr. Paddy Barrett

SEPTEMBER 19, 2023

Atherosclerosis. 9 Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. Curr Opin Lipidol. 2014 Feb;25(1):40-7. 2021 Aug;331:20-27. 7 HAUSER-RCT Investigators. Evolocumab in Pediatric Heterozygous Familial Hypercholesterolemia. N Engl J Med. 2020 Oct 1;383(14):1317-1327. J Lipid Res.

Dementia 52

Dementia Cholesterol Biomarkers Coronary Artery Disease 52

Cardiometabolic Health Congress

NOVEMBER 22, 2024

From breakthrough medications to innovative technologies, there is a lot for cardiometabolic clinicians professionals to celebrate. Personalized Cardiometabolic Care TRANSFORM Program for Coronary Artery Disease (CAD) : The TRANSFORM program focuses on atherosclerosis-based care strategies rather than traditional risk-based approaches.

Blood Pressure 59

Blood Pressure Obesity Preserved Ejection Fraction Coronary Artery Disease 59

Frontiers in Cardiovascular Medicine

FEBRUARY 12, 2025

TMYXP exerts anti-CHD effects on the TNF signaling pathway, PI3K-Akt signaling pathway, p53 signaling pathway, MAPK signaling pathway, lipid and atherosclerosis, NOD-like receptor signaling pathway, diabetic cardiomyopathy and cytokine-cytokine receptor interaction.

Pharmacology 52

Pharmacology Heart Disease Atherosclerosis Risk Factors 52